Zura Bio Limited Warrants
ZURAW
ZURAW was delisted on the 27th of August, 2024.
0 hedge funds and large institutions have $0 invested in Zura Bio Limited Warrants in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.
100% less funds holding
Funds holding: 14 → 0 (-14)
100% less capital invested
Capital invested by funds: $1.13M → $0 (-$1.13M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 14
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$211K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$185K |
| 3 |
BGIM
Boussard & Gavaudan Investment Management
London,
United Kingdom
|
-$85.8K |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$80K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$79.8K |
ZURAW Hedge Fund Activity: Q3 2024 in Review
0 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Zura Bio Limited Warrants (ZURAW) for Q3 2024, worth a combined $0 — down 100% from $1.13M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ZURAW and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Meteora Capital, exiting entirely with an estimated $211K sold.
- 0 institutional investors held Zura Bio Limited Warrants (ZURAW) as of Q3 2024, down from 14 in Q2 2024.
- Funds reported $0 of Zura Bio Limited Warrants stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Zura Bio Limited Warrants positions in Q3 2024 and 14 closed out, a net change of -14 holders.
- The largest Zura Bio Limited Warrants seller in Q3 2024 was Meteora Capital, an estimated $211K sold.
Based on aggregated 13F filings for Q3 2024.